Evaluation of Interleukin-8 in Hepatitis C Virus Infection: Relation to Combined peg-interferon Ribavirin Response and Genotype 4

REFERENCES

• Baggiolini, M., Dewald, B., Moser, B. (1994). Interleukin-8 and related chemotactic cytokines–CXC and CC chemokines. Adv. Immunol. 55:97–179.
   PubMed Web of Science ®Google Scholar
• Balasubramanian, A., Ganju, R. K., Groopman, J. E. (2003). Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J. Biol. Chem. 278:35755–35766.
   PubMed Web of Science ®Google Scholar
• Bosco, M. C., Gusella, G. L., Espinoza-Delgado, I., Longo, D. L., Varesio, L. (1994). Interferon-gamma upregulates interleukin-8 gene expression in human monocytic cells by a posttranscriptional mechanism. Blood 83:537–542.
   PubMedGoogle Scholar
• Cacopardo, B., Nigro, L., Nunnari, G., Medica, G. L., Cappellani, A., Palermo, F., Cappello, E., Russo, R. (2008). Association between raised IL-8 serum levels and resistance to combined peg-interferon ribavirin therapy in HCV+ active chronic hepatitis. Infez. Med. 16(2): 80–85.
   Google Scholar
• El Serag, H. B. (2002). Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36:S74–S83.
   PubMed Web of Science ®Google Scholar
• Fang, S. H., Lai, M. Y., Hwang, L. H., Yang, P. M., Chen, P. J., Chiang, B. L., (2001). Ribavirin enhances interferon- γ levels in patients with chronic hepatitis C treated with interferon-α. J. Biomed. Sci. 8(6):484–491.
   Google Scholar
• Feld, J. J., Lutchman, G. A., Heller, T., Hara, K., Pfeiffer, J. K., Leff, R. D., (in press). Ribavirin improves early responses to peginterferon through enhanced interferon signaling. Gastroenterology, Accepted Manuscript, Available online 17 March 2010.
   Google Scholar
• Francois, C., Duverlie, G., Rebouillat, D., Khorsi, H., Castelain, S., Blum, H. E., (2000). Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J. Virol. 74:5587–5596.
   PubMed Web of Science ®Google Scholar
• Frank, C., Mostafa, M., Strickland, G. T., Lavanchy, D., Arthur, R., Madgder, L., (2000). The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887–891.
   PubMed Web of Science ®Google Scholar
• Girard, S., Shalhoub, P., Lescure, P., Sabile, A., Misek, D. E., Hanash, S., (2002). An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 295:272–283.
   PubMed Web of Science ®Google Scholar
• Guillou-Guillemette, H. L., Vallet, S., Gaudy-Graffin, C., Payan, C., Pivert, A., Goudeau, A., Lunel-Fabiani, F. (2007). Genetic diversity of the hepatitis C virus: Impact and issues in the antiviral therapy. World J. Gastroenterol. 13(17):2416–2426.
   Google Scholar
• Halim, A. B., Garry, R. F., Srikanta, D., Berber, M. A. (1990). Effect of schistosomiasis and hepatitis on liver disease. Am. J. Trop. Med. Hyg. 60:915–920.
   Google Scholar
• Heintges, T., Wands, J. (1997). Hepatitis C virus: epidemiology and transmission. Hepatology 26:521–526.
   PubMed Web of Science ®Google Scholar
• Kamal, S., Madwar, M., Bianchi, L., Tawil, A., Fawzy, R., Peter, T. (2000). Clinical, virological and histological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 20:281–289.
   Google Scholar
• Kamel, M. A., Gaffar, Y. A., Wasef, M. A., Wright, M., Clark, L. C., DeWolf Miller, F. (1992). High HCV prevalence in Egyptian blood donors. Lancet 340:427–429.
   PubMed Web of Science ®Google Scholar
• Kanai, K., Kako, M., Okamoto, H. (1992). HCV genotypes in chronic hepatitis C and response to interferon. Lancet 339:1543.
   PubMed Web of Science ®Google Scholar
• Kato, N., Yoshida, H., Kioko Ono-Nita, S., Kato, J., Goto, T., Otsuka, M. (2000). Activation of intracellular signaling by hepatitis B and C viruses: C viral core is the most potent signal inducer. Hepatology 32:405–412.
   PubMed Web of Science ®Google Scholar
• Khabar, K. S., Al Zoghaibi, F., Al Ahdal, M. N., Murayama, T., Dhalla, M., Mukaida, N. (1997). The alpha chemokine, interleukin-8, inhibits the antiviral action of interferon alpha. J. Exp. Med. 186:1077–1085.
   PubMed Web of Science ®Google Scholar
• Khabar, K. S., Al Zoghaibi, F., Murayama, T., Matsushima, K., Mukaida, N., Siddiqui, Y., (1997). Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line. Biochem. Biophys. Res. Commun. 235:774–778.
   PubMed Web of Science ®Google Scholar
• Neuman MG, Sha K, Esguerra R, Zakhari S, Winkler RE, Hilzenrat N, Wyse J, Cooper CL, Seth D, Gorrell MD, Haber PS, McCaughan GW, Leo MA, Lieber CS, Voiculescu M, Buzatu E, Ionescu C, Dudas J, Saile B, and Ramadori G. (2008). Inflammation and repair in viral hepatitis C. Dig Dis Sci. 53(6):1468–1487.
   PubMed Web of Science ®Google Scholar
• Neuman, M. G., Benhamou, J. P., Martinot, M., Boyer, N., Shear, N. H., Malkiewicz, I. (1999). Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. Clin. Biochem. 32:537–545.
   PubMed Web of Science ®Google Scholar
• Ohno, O., Mizokami, M., Wu, R. R., Saleh, M. G., Ohba, K., Orito, E., Mukaide, M., Williams, R., Lau, J. Y. (1997). New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J. Clin. Microbiol. 35(1):201–207.
   PubMed Web of Science ®Google Scholar
• Oliveira, I. C., Sciavolino, P. J., Lee, T. H., Vilcek, J. (1992). Down regulation of interleukin-8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc. Natl. Acad. Sci. USA 89:9049–9053.
   PubMed Web of Science ®Google Scholar
• Oppenheim, J. J., Zachariae, C. O., Mukaida, N., Matsushima, K. (1991). Properties of the novel proinflammatory supergene ‘intercrine’ cytokine family. Annu. Rev. Immunol, 9:617–648.
   PubMed Web of Science ®Google Scholar
• Paterson, M., Laxton, C. D., Thomas, H. C., Ackrill, A. M., Foster, G. R. (1999). Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response. Gastroenterology 117:1187–1197.
   PubMed Web of Science ®Google Scholar
• Polyak, S. J., Khalid, S., Khabar, A., Rezeiq, M., Gretch, D. R. (2001a). Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J. Virol. 75(13): 6209–6211.
   PubMed Web of Science ®Google Scholar
• Polyak, S. J., Khabar, K. S., Paschal, D. M., Ezelle, H. J., Duverlie, G., Barber, G. N., (2001b). Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 75:6095–6106.
   PubMed Web of Science ®Google Scholar
• Sarrazin, C., Berg, T., Lee, J. H., Teuber, G., Dietrich, C. F., Roth, W. K., Zeuzem, S. (1999). Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b. Hepatology 30(6):1004–1013.
   Google Scholar
• Schnyder-Candrian, S., Strieter, R. M., Kunkel, S. L., Walz, A. (1995). Interferon alpha and interferon-gamma down-regulate the production of interleukin-8 and ENA-78 in human monocytes. J. Leukoc. Biol. 57:929–935.
   PubMed Web of Science ®Google Scholar
• Strickland, T. G., Elhefni, H., Salman, T., Waked, I., Abdel-Hamid, M., Mikhail N. (2002)/ Role of hepatitis C infection in chronic liver disease in Egypt. Am. J. Trop. Med. Hyg. 67:436–442.
   PubMed Web of Science ®Google Scholar
• Taub, D. D., Oppenheim, J. J. (1994). Chemokines, inflammation and the immune system. Ther. Immunol. 1:229–246.
   PubMedGoogle Scholar
• Yasumoto, K., Okamoto, S., Mukaida, N., Murakami, S., Mai, M., Matsushima, K. (2002). Tumor necrosis factor alpha and interferon gamma An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 295:272–283.
   Google Scholar